Epilepsy Flashcards
Otahara syndrome:
- Onset
- Seizure type
- other features
- EEG (interictal)
- EEG (ictal)
- Onset: first 10 days of life
- Seizure types: Multiple clusters of tonic spasms
- Other features: hypotonia, developmental arrest
- EEG Interictal: burst suppression
- High amplitude spike-and-wave followed by generalized fast activity (figure)
What is this?
Forehead plaque (Tuberous sclerosis)
Most common abnormal Brain finding in patients with temporal lobe epilepsy
- Mesial temporal sclerosis
most common gene associated with epilepsy of infancy with migrating focal seizures
KCNT1
Rate of depression in epilepsy
30%
Common EEG abnormalities with Temporal lobe epilepsies
- Temporal spikes and sharp waves (duh)
- Temporal delta slowing (TIRDA)
Most common genetic cause for frontal lobe epilepsy
Autosomal dominant frontal nocturnal epilepsy: acetylcholine receptor (Ach-R) mutation
Epilepsy localization by semiology: Frontal lobe
- Fencer posture
- hyperkinetic behaviors (rocking, bicycling, pelvic thrusting, back arching)
- Focal clonic movements
- Fencer Posture = Supplementary motor area (tonic / dystonic features)
- Hyperkinetic behaviors = Dorsolateral / orbitofrontal
- Focal clonic = posterior frontal
Channels (2) and receptors (2) most commonly affected in childhood absence epilepsy
- Calcium and chloride channels
- GABA-A and GABA-B receptors
Treatments for absence epilepsy (4) and drugs to avoid (4)
Treatment:
- Ethosuximide (first line)
- valproate
- lamotrigine
- levetiracetam
Avoid:
- carbamazepibne
- vigabatrin
- tiagabine
- phenytoin
Treatments (5) and drugs to avoid (2) in Juvenile myoclonic epilepsy
Treatment
- Valproate (first line if not a woman of childbearing age)
- levetiracetam
- lamotrigine
- topiramate
- zonisamide
Drugs to avoid
- carbamazepine
- oxcarbazepine
Genes associated with juvenile myoclonic epilepsy (per BtB)
(3)
- EFHC1
- GABRA1
- CLCH2
Age-range an peak onsest for Lennox-Gastaut Syndrome
1-8 years
Peak is 3-5 years
Drug known to increase drop-attacks in LGS
Carbemazepine
Typical age of onset of Landau-Kleffner syndrome
2-11 years
Mechanisms of action:
- Phenobarbital
- Phenytoin
- Carbamazepine
- Ethosuximide
- Valproic acid
- Phenobarbital: GABA enhancer
- Phenytoin: Na+ blocker
- Carbamazepine: Na+ blocker
- Ethosuximide: Ca++ blocker
- Valproic Acid: Na+ blocker, Ca++ blocker, GABA enhancer
Side Effects:
Phenytoin (7)
- Drowsiness
- Nausea
- Ataxia
- Gingival hyperplasia
- Rash
- Neuropathy
- Cardiac suppression (was originally used as an anti-arrhythmic
Side Effects:
Carbamazepine (6)
- Dizziness
- Nausea
- Ataxia
- Double vision
- thrombocytopenia
- Leukopenia
Side Effects:
Phenobarbital (2)
- Sedation
- “mental slowing”
Side Effects:
Ethosuximide (5)
- Drowsiness
- Confusion
- Insomnia
- Headache
- Ataxia
Side Effects: Valproate
“CNS” (4)
“GI” (5)
“Female” (2)
Other (1)
- “CNS-related”
- Drowsiness
- Dizziness
- Ataxia
- Tremor
- GI
- nausea
- weight gain
- Transaminitis
- Pancreatitis
- Eosinophilic colitis
- “Female”
- Teratogenicity
- PCOS
- Other: hair loss